Fundies. English
Segment disclosures
Company overviewZENAS BIOPHARMA, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
1 dimension combinations 11 retained observations 7 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Single Reportable Segment
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=zbio:SingleReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1000000 | Unit_Standard_USD_a7NFRpLArEKNOdVcUT0vjw | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1000000 | Unit_Standard_USD_a7NFRpLArEKNOdVcUT0vjw | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 10000000 | Unit_Standard_USD_sEvDbHMtFEeao_rQ42TbXw | 20260316 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 10000000 | Unit_Standard_USD_mNAzAr1wxkKBerrOtplWSg | 20251112 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 10000000 | Unit_Standard_USD_a7NFRpLArEKNOdVcUT0vjw | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 10000000 | Unit_Standard_USD_jnJZPeyNHE6ew5zfkp_nKg | 20250812 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 10000000 | Unit_Standard_USD_o0OUStLnFUu-zsb42nCsDw | 20260513 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 10000000 | Unit_Standard_USD_uyK7ptJXa0mOwkqv8AuXSQ | 20250515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 5000000 | Unit_Standard_USD_sEvDbHMtFEeao_rQ42TbXw | 20260316 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 5000000 | Unit_Standard_USD_wdROCaDSE0qp-UgQ8kIjMA | 20250311 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 50000000 | Unit_Standard_USD_wdROCaDSE0qp-UgQ8kIjMA | 20250311 | Open filing evidence |